Iron Oxide Nanoparticle Encapsulated Diatoms for Magnetic Delivery of Small Molecules to Tumors

Overview

Journal Nanoscale

Specialty Biotechnology

Date 2014 Jan 16

PMID 24424277

Citations 18

Authors

Trever Todd

Zipeng Zhen

Wei Tang

Hongmin Chen

Geoffrey Wang

Yen-Jun Chuang

Kayley Deaton

Zhengwei Pan

Jin Xie

Affiliations

Soon will be listed here.

Abstract

Small molecules can be co-loaded with iron oxide nanoparticles onto diatoms. With an external magnetic field, the diatoms, after systemic administration, can be attracted to tumors. This study suggests a great potential of diatoms as a novel and powerful therapeutic vehicle.

Citing Articles

A Descriptive Review on the Potential Use of Diatom Biosilica as a Powerful Functional Biomaterial: A Natural Drug Delivery System.

Kang S, Woo Y, Seo Y, Yoo D, Kwon D, Park H Pharmaceutics. 2024; 16(9).

PMID: 39339207 PMC: 11434644. DOI: 10.3390/pharmaceutics16091171.

Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells.

Neves A, Albuquerque T, Faria R, Santos C, Vives E, Boisguerin P Pharmaceutics. 2024; 16(6).

PMID: 38931902 PMC: 11207567. DOI: 10.3390/pharmaceutics16060781.

Recent Progress in Diatom Biosilica: A Natural Nanoporous Silica Material as Sustained Release Carrier.

Lim H, Seo Y, Kwon D, Kang S, Yu J, Park H Pharmaceutics. 2023; 15(10).

PMID: 37896194 PMC: 10609864. DOI: 10.3390/pharmaceutics15102434.

Algae: A Robust Living Material Against Cancer.

Xin Z, Zhang M, Cui H, Ding X, Zhang T, Wu L Int J Nanomedicine. 2023; 18:5243-5264.

PMID: 37727650 PMC: 10506609. DOI: 10.2147/IJN.S423412.

Diatom-Based Nanomedicine for Colorectal Cancer Treatment: New Approaches for Old Challenges.

Tramontano C, De Stefano L, Rea I Mar Drugs. 2023; 21(5).

PMID: 37233460 PMC: 10222510. DOI: 10.3390/md21050266.

References

Maeda H, Bharate G, Daruwalla J . Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2008; 71(3):409-19. DOI: 10.1016/j.ejpb.2008.11.010. View

Zhu C, Lu C, Song X, Yang H, Wang X . Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. J Am Chem Soc. 2011; 133(5):1278-81. DOI: 10.1021/ja110094g. View

Willmott N, Chen Y, Goldberg J, McArdle C, Florence A . Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats. J Pharm Pharmacol. 1989; 41(7):433-8. DOI: 10.1111/j.2042-7158.1989.tb06496.x. View

Bhattacharyya S, Wang H, Ducheyne P . Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules. Acta Biomater. 2012; 8(9):3429-35. DOI: 10.1016/j.actbio.2012.06.003. View

Huang X, Peng X, Wang Y, Wang Y, Shin D, El-Sayed M . A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano. 2010; 4(10):5887-96. PMC: 2964428. DOI: 10.1021/nn102055s. View

Lu J, Liong M, Li Z, Zink J, Tamanoi F . Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small. 2010; 6(16):1794-805. PMC: 2952648. DOI: 10.1002/smll.201000538. View

Maeda H . Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci. 2012; 88(3):53-71. PMC: 3365245. DOI: 10.2183/pjab.88.53. View

Losic D, Yu Y, Sinn Aw M, Simovic S, Thierry B, Addai-Mensah J . Surface functionalisation of diatoms with dopamine modified iron-oxide nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies. Chem Commun (Camb). 2010; 46(34):6323-5. DOI: 10.1039/c0cc01305f. View

Slowing I, Vivero-Escoto J, Wu C, Lin V . Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008; 60(11):1278-1288. DOI: 10.1016/j.addr.2008.03.012. View

10.

Xie J, Wang J, Niu G, Huang J, Chen K, Li X . Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. Chem Commun (Camb). 2010; 46(3):433-5. PMC: 3617810. DOI: 10.1039/b917195a. View

11.

Yi D, Selvan S, Lee S, Papaefthymiou G, Kundaliya D, Ying J . Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J Am Chem Soc. 2005; 127(14):4990-1. DOI: 10.1021/ja0428863. View

12.

Prabhakar U, Maeda H, Jain R, Sevick-Muraca E, Zamboni W, Farokhzad O . Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013; 73(8):2412-7. PMC: 3916009. DOI: 10.1158/0008-5472.CAN-12-4561. View

13.

Fang J, Nakamura H, Maeda H . The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2010; 63(3):136-51. DOI: 10.1016/j.addr.2010.04.009. View

14.

Lu C, Hung Y, Hsiao J, Yao M, Chung T, Lin Y . Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007; 7(1):149-54. DOI: 10.1021/nl0624263. View

15.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

16.

Liu T, Li L, Teng X, Huang X, Liu H, Chen D . Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials. 2010; 32(6):1657-68. DOI: 10.1016/j.biomaterials.2010.10.035. View

17.

Quan Q, Xie J, Gao H, Yang M, Zhang F, Liu G . HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm. 2011; 8(5):1669-76. PMC: 3185217. DOI: 10.1021/mp200006f. View

18.

Brannon-Peppas L, Blanchette J . Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004; 56(11):1649-59. DOI: 10.1016/j.addr.2004.02.014. View

19.

Delgado A, Soriano I, Sanchez E, Oliva M, Evora C . Radiolabelled biodegradable microspheres for lung imaging. Eur J Pharm Biopharm. 2000; 50(2):227-36. DOI: 10.1016/s0939-6411(00)00109-0. View